Timo A Thumann, Eva-Maria Pferschy-Wenzig, Christina Kumpitsch, Stefanie Duller, Christoph Högenauer, Patrizia Kump, Heba Aziz-Kalbhenn, Ramy M Ammar, Sabine Rabini, Christine Moissl-Eichinger, Rudolf Bauer
UNLABELLED: STW 5, a blend of nine medicinal plant extracts, exhibits promising efficacy in treating functional gastrointestinal disorders, notably irritable bowel syndrome (IBS). Nonetheless, its effects on the gastrointestinal microbiome and the role of microbiota on the conversion of its constituents are still largely unexplored. This study employed an experimental ex vivo model to investigate STW 5's differential effects on fecal microbial communities and metabolite production in samples from individuals with and without IBS...
May 13, 2024: Microbiology Spectrum